Luis Brieva Ruiz
Grau: Doctor/a
973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: https://www.researcherid.com/rid/E-8505-2019
Grups
Publicacions
-
Oreja-Guevara, C; Landete, L; Sagrado, MAR; Moya, I; Revilla, BA; Real, HD; Pinto, MLB; Harty, G; Fenwick, E; Sigworth, E; Ruiz, LB
From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis
JOURNAL OF MEDICAL ECONOMICS 29 1764-1778. .
-
Fernández, O; Montalban, X; Arés, A; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Caminero, AB; Castillo-Triviño, T; Costa-Frossard, L; Eichau, S; Landete, L; Llaneza, M; Llufriu, S; Meca-Lallana, JE; Meca-Lallana, V; Monreal, E; Moral, E; Oreja-Guevara, C; Prieto, JM; Romero-Pinel, L; Rovira, A; Rodríguez-Antigüedad, A
XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part II)
REVISTA DE NEUROLOGIA 81 55658-55658. .
-
Fernández, O; Montalban, X; Arés, A; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Caminero, AB; Castillo-Triviño, T; Costa-Frossard, L; Eichau, S; Landete, L; Llaneza, M; Llufriu, S; Meca-Lallana, JE; Meca-Lallana, V; Monreal, E; Moral, E; Oreja-Guevara, C; Prieto, JM; Romero-Pinel, L; Rovira, A; Rodríguez-Antigüedad, A
XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part I)
REVISTA DE NEUROLOGIA 81 51701-51701. .
-
Agundez-Moreno, A; Presas-Rodríguez, S; González-García, AM; Teniente-Serra, A; Arcos-Ribas, B; Martínez-Caceres, EM; Querol, L; Martín-Aguilar, L; Vidal-Jordana, A; Lallana, JEM; Dos-Santos, C; Millan, J; Valero, G; Cano, A; Casado, V; Boltes-Alandi, A; Hervas-Garcia, JV; Brieva, L; Alvarez, G; Ramo-Tello, C
Biological and clinical stability after switching from intravenous to subcutaneous natalizumab in RRMS under standard and extended dosing
Frontiers in Immunology 17 1879496-1879496. .
-
Torres, P; Sánchez, AG; Sancho-Saldaña, A; Quibus, L; Murillo, ES; Ruiz-Fernández, E; Peralta, S; Solana, MJ; Brieva, L; González-Mingot, C
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis
MOLECULAR NEUROBIOLOGY 63 -. .
-
Costa-Frossard, L; Brieva, L; García-Estévez, DA; Martín-Martínez, JM; Alvarez-Bravo, G; Blasco-Quílez, MR; Meca-Lallana, JE; Calles-Hernández, MC; Tello, CR; Muñoz-Fernández, C; Barbero, DE; López-Muñoz, P; González, JMP; Candeliere-Merlicco, A; Carmona, O; Riancho, J; Sola-Valls, N; Carcelén-Gadea, M; Borrega, L; Gascón-Giménez, F; Vilanova, D; Pérez, X; Villar, LM
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 27 -. .
-
Strijbis, E; Mostert, J; D'Haeseleer, M; Moral, E; Ruiz, LB; Comtois, J; Killestein, J; Repovic, P; McPherson, T; Cutter, G; Koch, M
Diminishing returns of disease-modifying treatment in older participants of MS clinical trials
Multiple Sclerosis Journal 32 429-439. .
-
Fernández, O; Arés, A; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Caminero, AB; Castillo-Triviño, T; Costa-Frossard, L; Eichau, S; Hernández, MA; Landete, L; Llaneza, M; Llufriu, S; Meca-Lallana, JE; Meca-Lallana, V; Moral, E; Oreja-Guevara, C; Prieto, JM; Romero-Pinel, L; Vilaseca, A; Rodríguez-Antigüedad, A
XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (I)
REVISTA DE NEUROLOGIA 81 39227-39227. .
-
Fernández, O; Arés, A; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Caminero, AB; Castillo-Triviño, T; Costa-Frossard, L; Eichau, S; Hernández, MA; Landete, L; Llaneza, M; Llufriu, S; Meca-Lallana, JE; Meca-Lallana, V; Moral, E; Oreja-Guevara, C; Prieto, JM; Romero-Pinel, L; Vilaseca, A; Rodríguez-Antigüedad, A
XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (II)
REVISTA DE NEUROLOGIA 81 39228-39228. .
-
Mostert, J; Strijbis, EM; D'Haeseleer, M; Moral, E; Brieva, L; Comtois, J; Repovic, P; Bowen, JD; Cutter, G; Koch, M
Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 97 229-238. .
-
Gómez-Ballesteros, R; de la Maza, SS; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco-Quílez, MR; García-Soto, JD; Rodríguez-Regal, A; Navarro-Cantó, L; Agüera, E; Garcés-Redondo, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervás, M; Castillo-Triviño, T; Maurino, J
Threatening illness perception and associated factors in early-stage relapsing-remitting multiple sclerosis
Frontiers in Psychiatry 16 1565150-1565150. .
-
Sancho-Saldaña, A; Gil-Sánchez, A; Quirant-Sánchez, B; Boigues, M; Canudes, M; Peralta, S; Solana, MJ; González-Mingot, C; Quibus, L; Martínez-Cáceres, E; Torres, P; Hervás, JV; Moreno-Magallon, J; Brieva, L
Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months
Journal of Clinical Medicine 14 -. .
Projectes
- Contribución de los productos finales de la glicación avanzada (AGEs) a la fisiopatología neurocognitiva de la esclerosis múltiple: Desvelando el daño silencioso. CAGEP-EM
- PROLILEM: DesEMmascarando la Esclerosis Múltiple con biomarcadores pronósticos liídicos
- EMCOVID-19: Esclerosis Múltiple y COVID-19
- "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
- UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO
